(S)-N-((S)-Quinuclidin-3-yl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide, 97%, 5g

6,7-Dimethoxyquinazoline-2,4-dione>98.0%(HPLC)(T)25g

(4-Bromo-phenyl)-acetyl chloride, 95.0%, 10g

ethyl 2,4-dioxo-4-(3,4,5-trimethoxyphenyl)butanoate, 95.0%, 10g

Fmoc-D-Cit-OH, 98%, 10g

N-Boc-2-Amino-5-bromopyrimidine, 95.0%, 10g

Ethyl N-(mesitylsulfonyl)oxyacetimidate, 95.0%, 100g

(R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(allyloxy)-5-oxopentanoic acid, 97%, 10g

Ethyl 4-chloro-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate, 95.0%, 100mg

(Z)-2-(2-((tert-Butoxycarbonyl)amino)thiazol-4-yl)pent-2-enoic acid, 95.0%, 10g

(R)-2-Methoxypropan-1-amine hydrochloride, 95.0%, 25g

Methyl 3-Hydroxy-2-thiophenecarboxylate>97.0%(GC)1g

(S)-2,3-Dihydro-1H-inden-1-ol, 98%, 5g